HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kouji Yamamoto Selected Research

SHU 508 (Levovist)

1/2006Contrast-enhanced ultrasound examination of lymph nodes in different types of lymphoma.
10/2005The usefulness of 1.5 harmonic imaging ultrasonography with Levovist in the diagnosis of focal hepatic tumors.
9/20051.5 Harmonic Imaging Sonography with microbubble contrast agent improves characterization of hepatocellular carcinoma.
1/2005Usefulness of digital subtraction imaging with Levovist in the diagnosis of hepatocellular carcinomas.
2/2003The usefulness of digital subtraction imaging with Levovist in the diagnosis of focal hepatic tumors.
7/2002Diagnosis of hepatocellular carcinoma using digital subtraction imaging with the contrast agent, Levovist: comparison with helical CT, digital subtraction angiography, and US angiography.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kouji Yamamoto Research Topics

Disease

14Neoplasms (Cancer)
02/2024 - 07/2002
7Hepatocellular Carcinoma (Hepatoma)
01/2022 - 07/2002
5Periodontitis
05/2009 - 03/2003
4Colorectal Neoplasms (Colorectal Cancer)
02/2024 - 01/2022
3Hemorrhage
01/2024 - 05/2010
3Infections
02/2022 - 01/2014
3Sepsis (Septicemia)
02/2018 - 01/2015
3Rheumatoid Arthritis
05/2010 - 12/2007
3Chronic Periodontitis
04/2004 - 09/2000
2Inflammation (Inflammations)
08/2021 - 06/2014
2Insulin Resistance
01/2020 - 01/2019
2Disseminated Intravascular Coagulation
02/2018 - 06/2015
2ST Elevation Myocardial Infarction
01/2018 - 10/2012
2Critical Illness (Critically Ill)
06/2015 - 01/2014
2Chronic Hepatitis C
07/2010 - 01/2005
2Systemic Lupus Erythematosus (Libman-Sacks Disease)
03/2007 - 03/2003
2Hemangioma (Angioma)
10/2005 - 02/2003
1Heart Failure
04/2024
1Amyloidosis
11/2023
1Leukopenia
11/2023
1Pancreatic Neoplasms (Pancreatic Cancer)
11/2023
1Neutropenia
11/2023
1Ovarian Neoplasms (Ovarian Cancer)
05/2023
1Neurofibromatosis 1 (Neurofibromatosis Type I)
01/2023
1Neurofibroma
01/2023
1Brain Diseases (Brain Disorder)
01/2023
1Exanthema (Rash)
01/2023
1Stomatitis
01/2023
1Liver Cirrhosis (Hepatic Cirrhosis)
10/2022
1COVID-19
10/2021
1Malnutrition (Nutritional Deficiencies)
08/2021
1Asthma (Bronchial Asthma)
08/2021
1Otitis Media with Effusion
08/2021
1Breast Neoplasms (Breast Cancer)
07/2021
1Neurodevelopmental Disorders
04/2021

Drug/Important Bio-Agent (IBA)

6Immunoglobulin G (IgG)IBA
12/2007 - 09/2000
6Fc Receptors (Fc Receptor)IBA
12/2007 - 09/2000
6SHU 508 (Levovist)IBA
01/2006 - 07/2002
5Biomarkers (Surrogate Marker)IBA
02/2024 - 01/2015
5Contrast MediaIBA
04/2006 - 07/2002
4CytokinesIBA
05/2010 - 03/2007
3Bevacizumab (Avastin)FDA Link
02/2024 - 01/2023
2Panitumumab (Vectibix)FDA Link
02/2024 - 01/2023
2Aspartate Aminotransferases (Aspartate Transaminase)IBA
01/2024 - 07/2010
2Alanine Transaminase (SGPT)IBA
01/2024 - 07/2010
2Proteins (Proteins, Gene)FDA Link
10/2021 - 07/2021
23- (1,3- benzothiazol- 2- yl)- 4- (4- methoxyphenyl)but- 3- enoic acidIBA
07/2021 - 11/2018
2Uric Acid (Urate)IBA
01/2020 - 01/2019
2AdiponectinIBA
01/2020 - 01/2019
2Dacarbazine (DIC)FDA LinkGeneric
02/2018 - 06/2015
2ErythropoietinFDA Link
01/2018 - 10/2012
2Interleukin-1 (Interleukin 1)IBA
12/2007 - 03/2007
2Fc gamma receptor IIAIBA
03/2007 - 04/2004
1Epidermal Growth Factor (EGF)IBA
02/2024
1Endothelial Growth FactorsIBA
02/2024
1TransferasesIBA
01/2024
1N-acetyltalosaminuronic acid (NAT)IBA
11/2023
1GemcitabineFDA Link
11/2023
1Oxaliplatin (Eloxatin)FDA LinkGeneric
06/2023
1Irinotecan (Camptosar)FDA LinkGeneric
06/2023
1Paclitaxel (Taxol)FDA LinkGeneric
05/2023
1Carboplatin (JM8)FDA LinkGeneric
05/2023
1ErbB Receptors (EGF Receptor)IBA
01/2023
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2023
1Monoclonal AntibodiesIBA
01/2023
1Sirolimus (Rapamycin)FDA Link
01/2023
1Collagen Type IV (Type IV Collagen)IBA
10/2022
1Neutralizing AntibodiesIBA
02/2022
1Sorafenib (BAY 43-9006)FDA Link
01/2022
1lenvatinibIBA
01/2022
1Blood Proteins (Serum Proteins)IBA
10/2021
14- (4- dihexadecylaminostyryl)- N- methylpyridium (DiA)IBA
10/2021
1CholesterolIBA
08/2021
1AlbuminsIBA
08/2021
1Protein Kinases (Protein Kinase)IBA
07/2021
1Messenger RNA (mRNA)IBA
07/2021
1EnzymesIBA
07/2021
1Gold Sodium Thiomalate (Sodium Aurothiomalate)IBA
07/2021
1AntibodiesIBA
12/2020

Therapy/Procedure

7Therapeutics
04/2024 - 10/2019
4Drug Therapy (Chemotherapy)
02/2024 - 01/2022
2Injections
03/2018 - 06/2009
2Intravenous Administration
01/2018 - 10/2012
2Percutaneous Coronary Intervention
01/2018 - 10/2012
2Microbubbles
04/2006 - 09/2005
1Patient Readmission
04/2024
1Transcatheter Aortic Valve Replacement
11/2023
1Neoadjuvant Therapy
11/2023
1Chemoradiotherapy
11/2023
1Combination Drug Therapy (Combination Chemotherapy)
11/2023
1Punctures
01/2023
1Local Anesthesia
01/2023
1Tracheostomy
01/2023
1Genomic Medicine
12/2022
1Molecular Targeted Therapy
01/2022
1Middle Ear Ventilation (Tympanostomy)
08/2021
1Adenoidectomy
08/2021
1Long-Term Care
04/2021
1Immunotherapy
12/2020
1Knee Replacement Arthroplasty (Total Knee Replacement)
12/2020